J Med Microbiol 2012,61(Pt 6):762–5.PubMedCrossRef 24. Šmajs D, Karpathy SE, Šmarda J, Weinstock GM: Colicins produced by the Escherichia fergusonii strains closely resemble colicins encoded by Escherichia coli. FEMS Microbiol Lett 2002, 208:259–262.PubMedCrossRef 25. Chumchalová J, Šmarda J: Human tumor cells are selectively inhibited by colicins. Folia Microbiol (Praha) 2003, 48:111–115.CrossRef 26. Gordon DM, O’Brien CL: Bacteriocin diversity and the frequency of multiple bacteriocin production in Escherichia coli click here . Microbiology (Reading, Engl) 2006,152(11):3239–3244.CrossRef 27. Abraham S, Chapman TA, Zhang R, Chin J, Mabbett AN, Totsika M: Molecular characterization

of Escherichia coli strains that cause symptomatic and asymptomatic selleck chemicals llc urinary tract

infections. J Clin Microbiol 2012, 50:1027–30.PubMedCentralPubMedCrossRef 28. Gordon DM, Stern SE, Collignon selleck PJ: The influence of the age and sex of human hosts on the distribution of Escherichia coli ECOR groups and virulence traits. Microbiology 2005, 151:15–23.PubMedCrossRef 29. Riley MA, Gordon DM: A survey of Col plasmids in natural isolates of Escherichia coli and an investigation into the stability of Col-plasmid lineages. J Gen Microbiol 1992, 138:1345–1352.PubMedCrossRef 30. Achtman M, Mercer A, Kusecek B, Pohl A, Heuzenroeder M, Aaronson W, Sutton A, Silver RP: Six widespread bacterial clones among Escherichia coli K1 isolates. Infect Immun 1983, 39:315–335.PubMedCentralPubMed 31. Šmajs D, Čejková D, Micenková L, Lima-Bittencourt Buspirone HCl CI, Chartone-Souza E, Šmarda J, Nascimento AMA: Human Escherichia coli strains of different geographical and time source: bacteriocin types and their gene sequences are population-specific. Environ Microbiol

Rep 2012, 4:459–466.PubMedCrossRef 32. Šmarda J, Obdržálek V: Incidence of colicinogenic strains among human Escherichia coli. J Basic Microbiol 2001, 41:367–74.PubMedCrossRef 33. Connell I, Agace W, Klemm P, Schembri M, Marild S, Svanborg C: Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 1996, 93:9827–9832.PubMedCentralPubMedCrossRef 34. Hagberg L, Jodal U, Korhonen TK, Lidin-Janson G, Lindberg U, Edén CS: Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun 1981, 31:564–570.PubMedCentralPubMed 35. Leffler H, Svanborg-Eden C: Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect Immun 1981, 34:920–929.PubMedCentralPubMed 36. Edén CS, Freter R, Hagberg L, Hull R, Hull S, Leffler H, Schoolnik G: Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature 1982, 298:560–562.PubMedCrossRef 37.